| Jesica Wayman, | |
|
77 S 600 E Ste C, Price, UT 84501-3174 | |
| (435) 613-7289 | |
| Not Available |
| Full Name | Jesica Wayman |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 77 S 600 E Ste C, Price, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972259992 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | PN.0043842 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jesica Wayman, Po Box 867, Price, UT 84501-0867 Ph: () - | Jesica Wayman, 77 S 600 E Ste C, Price, UT 84501-3174 Ph: (435) 613-7289 |
News Archive
For people who are hospitalized for traumatic brain injury, recovery may involve physical and cognitive problems that linger for years. The road back to health can be even more arduous for those who live in remote rural areas and don't have access to brain rehabilitation specialists. Mayo Clinic and collaborators, have received a $2.2 million federal grant to test new ways to provide specialized TBI care, with a focus on reaching rural areas and underserved urban populations.
Ortho Clinical Diagnostics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has cleared the VITROS Chemistry Products HbA1c Reagent Kit to be used on the VITROS 5600 Integrated System, VITROS 4600 Chemistry System, and the VITROS 5,1 FS Chemistry System. The test can be used for the quantitative determination of percent glycated hemoglobin A1c (DCCT/NGSP) and mmol/mol hemoglobin A1c (IFCC) in human whole blood.
Protein Sciences Corporation announced today that the FDA has approved the Company's strain change amendment for its seasonal influenza vaccine, Flublok.
Cardiomyopathy is common among cardiac arrest survivors. The survival and neuroprotective benefits of therapeutic hypothermia is similar in patients with preexisting cardiomyopathy, compared with those patients without cardiomyopathy, according to a scientific poster being presented Nov. 14 at the American Heart Association (AHA) scientific sessions.
H. Lundbeck A/S and Otsuka Pharmaceutical Co., Ltd. announced today the continuation of the development program of Lu AE58054 for the treatment of Alzheimer's disease, initiating the first out of four phase III clinical trials with the compound.
› Verified 5 days ago
Kelly Ann Rubio, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 575 East 100 South, Price, UT 84501 Phone: 435-637-2358 Fax: 435-637-9141 | |
Autumn Rose Tonc, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 575 E. 100 S., Price, UT 84501 Phone: 435-637-2358 Fax: 435-637-9141 | |
Judy Anne Behling, L.P.N. Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 575 E. 100 S., Price, UT 84501 Phone: 435-637-2358 Fax: 435-637-9141 | |
John Barnett, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 77 S 600 E Ste C, Price, UT 84501 Phone: 435-613-7289 | |
Alanis Richarz, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 77 S 600 E Ste C, Price, UT 84501 Phone: 435-613-7289 | |
Daniel Quick-parry, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 575 East 100 South, Price, UT 84501 Phone: 435-637-7200 Fax: 435-637-2377 | |
Tamarisk Hanson, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 575 E 100 S, Price, UT 84501 Phone: 435-637-2358 |